Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Shares Sold by Cetera Investment Advisers

Key Points

• Cetera Investment Advisers reduced its stake in Sabra Healthcare REIT by 73.5%, owning 104,949 shares worth approximately $1.83 million after selling 291,132 shares in the first quarter.
• Sabra Healthcare REIT reported earnings per share of $0.38, exceeding analysts' estimates of $0.36, with revenue of $189.15 million for the quarter, reflecting a 7.4% annual growth.
• The company declared a quarterly dividend of $0.30, representing a 6.4% dividend yield, with a payout ratio of 157.89%.

Cetera Investment Advisers decreased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 73.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 104,949 shares of the real estate investment trust's stock after selling 291,132 shares during the period. Cetera Investment Advisers' holdings in Sabra Healthcare REIT were worth $1,833,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Northern Trust Corp boosted its stake in shares of Sabra Healthcare REIT by 27.7% in the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after acquiring an additional 905,466 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Sabra Healthcare REIT in the 4th quarter valued at $14,241,000. Wellington Management Group LLP boosted its stake in Sabra Healthcare REIT by 33.7% during the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after purchasing an additional 808,207 shares during the last quarter. Nuveen Asset Management LLC boosted its stake in Sabra Healthcare REIT by 30.8% during the 4th quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after purchasing an additional 795,902 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of Sabra Healthcare REIT by 109.4% during the fourth quarter. Barclays PLC now owns 1,420,356 shares of the real estate investment trust's stock worth $24,601,000 after buying an additional 741,959 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Trading Down 0.1%

Shares of Sabra Healthcare REIT stock traded down $0.02 during mid-day trading on Tuesday, hitting $18.63. The stock had a trading volume of 1,393,234 shares, compared to its average volume of 2,434,862. The firm has a 50-day moving average of $18.27 and a two-hundred day moving average of $17.57. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm has a market cap of $4.47 billion, a P/E ratio of 24.51, a price-to-earnings-growth ratio of 1.55 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. During the same quarter in the prior year, the company posted $0.36 EPS. The business's revenue for the quarter was up 7.4% on a year-over-year basis. Sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Insider Activity at Sabra Healthcare REIT

In other news, Director Michael J. Foster sold 11,000 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares in the company, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.10% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Scotiabank boosted their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. JMP Securities increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $20.00.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.